Fulcrum Therapeutics (FULC) Stock Forecast
Fulcrum Therapeutics Inc
Ninghpa hpeh$3.74Updated 25 Sep 2026 19:59 UTC
Change-1.32%
AI forecast: FULC
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Ninghtang 6 hpeh hta rai
Premium shi AI hpe 1 dai, 1 rai hte 1 hpa hpang hta a mung ai hpe 1 dai, 1 rai hte 1 hpa hpang hta a mung ai hpe shan ai.
Unlock Premium🔒 Ninghkang hpe hkum hkum hpe hta
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumNinghpaw hta mung
Fulcrum Therapeutics is a biopharmaceutical company focused on developing therapies for genetic diseases. The company has developed product candidates designed to modulate gene expression and potentially address the underlying causes of these conditions.
